BETA

Activities of Crescenzio RIVELLINI related to 2008/0261(COD)

Plenary speeches (3)

Explanations of vote
2016/11/22
Dossiers: 2008/0261(COD)
Explanations of vote
2016/11/22
Dossiers: 2008/0261(COD)
Explanations of vote
2016/11/22
Dossiers: 2008/0261(COD)

Amendments (5)

Amendment 89 #
Proposal for a directive – amending act
Recital 7 a (new)
(7a) Member States, together with stakeholders, should be free to determine the particular aspects of technologies for combating counterfeiting of pharmaceuticals which they consider most appropriate for their pharmaceutical distribution systems, taking account of the authentication seal adopted by this Directive.
2010/03/12
Committee: ENVI
Amendment 95 #
Proposal for a directive – amending act
Recital 11 a (new)
The internet is the main source of counterfeit pharmaceuticals. Members of the public should be strongly discouraged from acquiring pharmaceuticals through illegal distribution channels. It would therefore be desirable to organise education campaign(11a) The European public should be made aware of the risks run when purchasing pharmaceuticals through illegal channels, especially in terms of their danger to health. In particular, information campaigns should be promoted at both national and European level. The Commission, in conjunction with the Member States, should adopt effective measures to improve public awareness onf the subject at both national and European levelrisks arising from purchases of pharmaceuticals over the internet. Or. it Justification.
2010/03/12
Committee: ENVI
Amendment 248 #
Proposal for a directive – amending act
Article 1 - point 9
Directive 2001/83/EC
Article 54a – paragraph 4 – subparagraph 1
4. The Commission shall adopt the measures necessary for the implementation of point (o) of Article 54 and of paragraphs (1) and (2) of this Article. Before formulating a specific proposal, and in order to choose the option that best matches citizens' needs, the Commission shall perform an impact assessment of the costs and benefits of the anti- counterfeiting systems currently in force and seek the views of those involved in the implementation and use of such authenticating seals.
2010/03/12
Committee: ENVI
Amendment 287 #
Proposal for a directive – amending act
Article 1 - point 9
Directive 2001/83/EC
Article 54 a – paragraph 4 – subparagraph 5 a (new)
The measures referred to in this paragraph shall take due account of the legitimate interests to protect information of a commercially confidential nature and of the protection of industrial and commercial property rights. Member States shall undertake to ensure that the ownership and confidentiality of the data generated by using technology to combat counterfeiting of pharmaceutical products are respected.
2010/03/12
Committee: ENVI
Amendment 374 #
Proposal for a directive – amending act
Article 2 – paragraph 2 a (new)
2a. In accordance with the principle of subsidiarity enshrined in Article 5 of the Treaty on European Union, this Directive shall not in any way alter the right of Member States to impose restrictions on the sale of prescription pharmaceuticals over the internet.
2010/03/12
Committee: ENVI